TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-093896
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Hughes Eric A (See "Remarks")

Summary

Type

Sell

Net shares

-80,762

% of shares

-45.07%

Amount (USD)

$2,613,450

Insider confidence score

8.8 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Extreme scheduled sell (≥25% of shares)
  • Very large sell amount ($1M+)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+24,900.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

24,900.0

Transaction 2

Security

Ordinary Shares

Action

Sell

Date

2026-03-03

Code

S

Net shares

-12,077.0

Price per Share

$32.36

Amount (USD)

$390,810.51

Acquired/Disposed

Disposed

Shares Owned Before

24,900.0

Shares Owned After

12,823.0

Transaction 3

Security

Ordinary Shares

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+141,478.0

Acquired/Disposed

Acquired

Shares Owned Before

12,823.0

Shares Owned After

154,301.0

Transaction 4

Security

Ordinary Shares

Action

Sell

Date

2026-03-03

Code

S

Net shares

-68,685.0

Price per Share

$32.36

Amount (USD)

$2,222,639.73

Acquired/Disposed

Disposed

Shares Owned Before

154,301.0

Shares Owned After

85,616.0

Derivative Transactions

Transaction 1

Security

Restricted Share Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-24,900.0

Acquired/Disposed

Disposed

Shares Owned Before

49,801.0

Shares Owned After

24,901.0

Transaction 2

Security

Restricted Share Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-141,478.0

Acquired/Disposed

Disposed

Shares Owned Before

141,478.0

Shares Owned After

0.0

Filing's footnotes

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

3. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

4. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

6. Restricted share units were granted on March 3, 2023, with 24,900 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.

7. Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.